C07D 233/76
With substituted hydrocarbon radicals attached to the third ring carbon atom
Official title: with substituted hydrocarbon radicals attached to the third ring carbon atom
C07D233/76 (With substituted hydrocarbon radicals attached to the third ring carbon atom) appears on 349 US grants and 214 published applications in this corpus.
Search patents in C07D- Granted patents
- 349
- Published applications
- 214
- Assignees
- 189
- Inventors
- 894
- Latest grant
- 7 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 3 | 0 |
| 1977 | 6 | 0 |
| 1978 | 11 | 0 |
| 1979 | 8 | 0 |
| 1980 | 18 | 0 |
| 1981 | 11 | 0 |
| 1982 | 6 | 0 |
| 1983 | 2 | 0 |
| 1984 | 13 | 0 |
| 1985 | 1 | 0 |
| 1986 | 2 | 0 |
| 1987 | 3 | 0 |
| 1988 | 0 | 0 |
| 1989 | 2 | 0 |
| 1990 | 6 | 0 |
| 1991 | 5 | 0 |
| 1992 | 4 | 0 |
| 1993 | 4 | 0 |
| 1994 | 4 | 0 |
| 1995 | 10 | 0 |
| 1996 | 12 | 0 |
| 1997 | 8 | 0 |
| 1998 | 6 | 0 |
| 1999 | 9 | 0 |
| 2000 | 13 | 0 |
| 2001 | 16 | 0 |
| 2002 | 15 | 12 |
| 2003 | 5 | 13 |
| 2004 | 7 | 22 |
| 2005 | 6 | 12 |
| 2006 | 7 | 12 |
| 2007 | 9 | 13 |
| 2008 | 6 | 8 |
| 2009 | 7 | 11 |
| 2010 | 9 | 13 |
| 2011 | 7 | 5 |
| 2012 | 6 | 10 |
| 2013 | 10 | 8 |
| 2014 | 7 | 5 |
| 2015 | 5 | 5 |
| 2016 | 2 | 11 |
| 2017 | 5 | 4 |
| 2018 | 9 | 10 |
| 2019 | 10 | 8 |
| 2020 | 6 | 11 |
| 2021 | 10 | 7 |
| 2022 | 1 | 4 |
| 2023 | 3 | 3 |
| 2024 | 8 | 5 |
| 2025 | 2 | 2 |
| 2026 | 4 | 0 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- 5-(3-bromophenyl)-3-((diethylamino)methyl)-5-methylimidazolidine-2,4-dioneas7 Jul 2026US 12,673,922 B1King Faisal University
- PSMA imaging agents24 Mar 2026US 12,583,887 B2Siemens Medical Solutions USA, Inc.
- PSMA imaging agents24 Feb 2026US 12,559,521 B2Siemens Medical Solutions USA, Inc.
- Polymeric disinfectants and uses thereof17 Feb 2026US 12,552,882 B2Technion Research & Development Foundation Limited
- Substituted hydantoinamides as ADAMTS7 antagonists26 Aug 2025US 12,398,120 B2Bayer Aktiengesellschaft
- Aryl hydantoin compounds and methods of use20 Nov 2025US 2025/0353819 A1Board of Regents of the University of Nebraska
- Hydantoin compound and medical use thereof1 May 2025US 2025/0136555 A1China Pharmaceutical University
- PSMA Imaging Agents26 Dec 2024US 2024/0425547 A1Siemens Medical Solutions USA, Inc.
- PSMA Imaging Agents12 Dec 2024US 2024/0409580 A1Siemens Medical Solutions USA, Inc.
- Rela/rsh inhibitors for the treatment or prevention of medical biofilms28 Nov 2024US 2024/0390337 A1Drexel University
Most cited
By later US patents
- Pharmaceutical formulations for parenteral use208US 5,024,998 AUniversity of Florida · 1991
- Pharmaceutical formulations for parenteral use93US 4,983,586 AUniversity of Florida · 1991
- Phenylimidazolidines having antiandrogenic activity85US 5,411,981 ARoussel Uclaf · 1995
- Known and selected novel arylmethylenyl derivatives of thiazolidinones, imidazolidinones and oxazolidinones useful as antiallergy agents and anti-inflammatory agents80US 5,208,250 AWarner-Lambert Company · 1993
- Optionally substituted phenylimidazolidines, their preparation process and intermediates, their use as medicaments and the pharmaceutical compositions containing them70US 5,750,553 ARoussel Uclaf · 1998